ITRM20040223A1 - Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi. - Google Patents

Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi.

Info

Publication number
ITRM20040223A1
ITRM20040223A1 IT000223A ITRM20040223A ITRM20040223A1 IT RM20040223 A1 ITRM20040223 A1 IT RM20040223A1 IT 000223 A IT000223 A IT 000223A IT RM20040223 A ITRM20040223 A IT RM20040223A IT RM20040223 A1 ITRM20040223 A1 IT RM20040223A1
Authority
IT
Italy
Prior art keywords
aspergillosis
medication
treatment
fungal infections
fungal
Prior art date
Application number
IT000223A
Other languages
English (en)
Inventor
Paolo Carminati
Luigina Romani
Giovanni Salvatori
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT000223A priority Critical patent/ITRM20040223A1/it
Publication of ITRM20040223A1 publication Critical patent/ITRM20040223A1/it
Priority to TW094113144A priority patent/TWI393569B/zh
Priority to PL05742910T priority patent/PL1750744T3/pl
Priority to KR1020067024870A priority patent/KR101192611B1/ko
Priority to CN2005800146549A priority patent/CN1950104B/zh
Priority to US11/579,805 priority patent/US8778389B2/en
Priority to MEP-2008-956A priority patent/ME02743B/me
Priority to SI200530310T priority patent/SI1750744T1/sl
Priority to AT05742910T priority patent/ATE397937T1/de
Priority to JP2007512731A priority patent/JP5574565B2/ja
Priority to DE602005007485T priority patent/DE602005007485D1/de
Priority to DK05742910T priority patent/DK1750744T3/da
Priority to PT05742910T priority patent/PT1750744E/pt
Priority to RSP-2008/0316A priority patent/RS50591B/sr
Priority to CA2563400A priority patent/CA2563400C/en
Priority to MXPA06012889A priority patent/MXPA06012889A/es
Priority to EP05742910A priority patent/EP1750744B1/en
Priority to AU2005239913A priority patent/AU2005239913B2/en
Priority to BRPI0510718-0A priority patent/BRPI0510718A/pt
Priority to ES05742910T priority patent/ES2306145T3/es
Priority to PCT/IT2005/000247 priority patent/WO2005107791A1/en
Priority to ARP050101819A priority patent/AR048775A1/es
Priority to HK07108219.1A priority patent/HK1103961A1/xx
Priority to HR20080413T priority patent/HRP20080413T3/xx
Priority to CY20081100978T priority patent/CY1108332T1/el
Priority to US14/296,073 priority patent/US20140296135A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
IT000223A 2004-05-07 2004-05-07 Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi. ITRM20040223A1 (it)

Priority Applications (26)

Application Number Priority Date Filing Date Title
IT000223A ITRM20040223A1 (it) 2004-05-07 2004-05-07 Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi.
TW094113144A TWI393569B (zh) 2004-05-07 2005-04-25 供治療真菌感染（特別是曲霉病）並包含ｐｔｘ３和抗真菌劑之藥劑
PCT/IT2005/000247 WO2005107791A1 (en) 2004-05-07 2005-04-28 Medicament for the treatment of fungal infections, particularly aspergillosis
PT05742910T PT1750744E (pt) 2004-05-07 2005-04-28 Medicamento para o tratamento de infecções fúngicas, principalmente da aspergilose
RSP-2008/0316A RS50591B (sr) 2004-05-07 2005-04-28 Lek za lečenje gljivičnih infekcija, naročito aspergiloze
CN2005800146549A CN1950104B (zh) 2004-05-07 2005-04-28 用于治疗真菌感染特别是曲霉病的药物
US11/579,805 US8778389B2 (en) 2004-05-07 2005-04-28 Medicament for the treatment of fungal infections particularly aspergillosis
MEP-2008-956A ME02743B (me) 2004-05-07 2005-04-28 Lek za lečenje gljivičnih infekcija, naročito aspergiloze
SI200530310T SI1750744T1 (sl) 2004-05-07 2005-04-28 Zdravilo za zdravljenje gliviäśnih infekcij, zlasti aspergiloze
AT05742910T ATE397937T1 (de) 2004-05-07 2005-04-28 Medikament zur behandlung von pilzinfektionen; insbesondere aspergillose
JP2007512731A JP5574565B2 (ja) 2004-05-07 2005-04-28 真菌感染、特にアスペルギルス症を処置するための医薬
DE602005007485T DE602005007485D1 (de) 2004-05-07 2005-04-28 Medikament zur behandlung von pilzinfektionen; insbesondere aspergillose
DK05742910T DK1750744T3 (da) 2004-05-07 2005-04-28 Lægemiddel til behandling af svampeinfektioner, især aspergillose
PL05742910T PL1750744T3 (pl) 2004-05-07 2005-04-28 Lek do leczenia infekcji grzybiczych, w szczególności aspergilozy
KR1020067024870A KR101192611B1 (ko) 2004-05-07 2005-04-28 진균 감염, 특히 아스페르길루스증 치료용 약제
CA2563400A CA2563400C (en) 2004-05-07 2005-04-28 Medicament for the treatment of fungal infections, particularly aspergillosis
MXPA06012889A MXPA06012889A (es) 2004-05-07 2005-04-28 Medicamento para el tratamiento contra infecciones fungicas particularmente espergilosis.
EP05742910A EP1750744B1 (en) 2004-05-07 2005-04-28 Medicament for the treatment of fungal infections, particularly aspergillosis
AU2005239913A AU2005239913B2 (en) 2004-05-07 2005-04-28 Medicament for the treatment of fungal infections, particularly aspergillosis
BRPI0510718-0A BRPI0510718A (pt) 2004-05-07 2005-04-28 medicamento para o tratamento de infecções fúngicas, particularmente a aspergilose
ES05742910T ES2306145T3 (es) 2004-05-07 2005-04-28 Medicamento para el tratamiento de infecciones fungicas, particularmente aspergilosis.
ARP050101819A AR048775A1 (es) 2004-05-07 2005-05-05 Un medicamento que comprende ptx3 y un agente antifungico para el tratamiento de infecciones fungicas particularmente aspergilosis
HK07108219.1A HK1103961A1 (en) 2004-05-07 2007-07-27 Medicament for the treatment of fungal infections, particularly aspergillosis
HR20080413T HRP20080413T3 (en) 2004-05-07 2008-08-26 Medicament for the treatment of fungal infections, particularly aspergillosis
CY20081100978T CY1108332T1 (el) 2004-05-07 2008-09-11 Φαρμακο για τη θεραπεια μυκητιακων λοιμωξεων, ειδικοτερα της ασπεργιλλωσης
US14/296,073 US20140296135A1 (en) 2004-05-07 2014-06-04 Medicament for the treatment of fungal infections particularly aspergillosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000223A ITRM20040223A1 (it) 2004-05-07 2004-05-07 Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi.

Publications (1)

Publication Number Publication Date
ITRM20040223A1 true ITRM20040223A1 (it) 2004-08-07

Family

ID=34968212

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000223A ITRM20040223A1 (it) 2004-05-07 2004-05-07 Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi.

Country Status (25)

Country Link
US (2) US8778389B2 (it)
EP (1) EP1750744B1 (it)
JP (1) JP5574565B2 (it)
KR (1) KR101192611B1 (it)
CN (1) CN1950104B (it)
AR (1) AR048775A1 (it)
AT (1) ATE397937T1 (it)
AU (1) AU2005239913B2 (it)
BR (1) BRPI0510718A (it)
CA (1) CA2563400C (it)
CY (1) CY1108332T1 (it)
DE (1) DE602005007485D1 (it)
DK (1) DK1750744T3 (it)
ES (1) ES2306145T3 (it)
HK (1) HK1103961A1 (it)
HR (1) HRP20080413T3 (it)
IT (1) ITRM20040223A1 (it)
ME (1) ME02743B (it)
MX (1) MXPA06012889A (it)
PL (1) PL1750744T3 (it)
PT (1) PT1750744E (it)
RS (1) RS50591B (it)
SI (1) SI1750744T1 (it)
TW (1) TWI393569B (it)
WO (1) WO2005107791A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040489A1 (it) * 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
ITMI20062448A1 (it) * 2006-12-19 2008-06-20 Univ Degli Studi Modena E Reggio Emilia Metodo per la diagnosi e/o il monitoraggio dell¿ aspergillosi invasiva
US8838152B2 (en) 2007-11-30 2014-09-16 Microsoft Corporation Modifying mobile device operation using proximity relationships
CN101280326B (zh) * 2008-05-14 2011-07-06 中国科学院微生物研究所 一种抑制烟曲霉活性的化合物制备方法及其应用
WO2013191280A1 (ja) * 2012-06-22 2013-12-27 国立大学法人 東京大学 全身性炎症反応症候群の治療又は予防剤
EP3803396B1 (en) * 2018-06-01 2023-03-01 B.R.A.H.M.S GmbH Biomarkers for the diagnosis of invasive fungal infections
EP3669885A1 (en) * 2018-12-20 2020-06-24 Humanitas Mirasole S.p.A. Use of sap for the treatment of eurotiomycetes fungi infections
CN113952401B (zh) * 2021-12-15 2022-10-25 河北农业大学 一种用于防治畜禽曲霉菌感染的中药及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
AU598958B2 (en) * 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
JP2001183375A (ja) 1999-12-27 2001-07-06 Tosoh Corp 酵素標識抗体
US20050187161A1 (en) * 2003-09-12 2005-08-25 Board Of Regents, The University Of Texas System Biopanning as an approach to study the pathogenesis of and produce novel treatment modalities for invasive Aspergillosis
WO2005091754A2 (en) * 2004-03-29 2005-10-06 University Of Mississippi Novel cyclopentenedione antifungal compounds and methods for their use
ITRM20040489A1 (it) * 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
ES2389452T3 (es) * 2006-05-02 2012-10-26 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Uso de timosina 1, sola o en combinación con PTX3 o ganciclovir, para el tratamiento de infección por citomegalovirus

Also Published As

Publication number Publication date
EP1750744A1 (en) 2007-02-14
AR048775A1 (es) 2006-05-24
US8778389B2 (en) 2014-07-15
US20140296135A1 (en) 2014-10-02
ME02743B (me) 2010-05-07
CA2563400A1 (en) 2005-11-17
RS50591B (sr) 2010-05-07
CN1950104A (zh) 2007-04-18
JP5574565B2 (ja) 2014-08-20
TWI393569B (zh) 2013-04-21
BRPI0510718A (pt) 2007-11-20
CY1108332T1 (el) 2014-02-12
CA2563400C (en) 2013-07-30
JP2007536380A (ja) 2007-12-13
ATE397937T1 (de) 2008-07-15
ES2306145T3 (es) 2008-11-01
HK1103961A1 (en) 2008-01-04
PT1750744E (pt) 2008-08-14
EP1750744B1 (en) 2008-06-11
AU2005239913A1 (en) 2005-11-17
MXPA06012889A (es) 2007-02-15
AU2005239913B2 (en) 2011-08-18
DE602005007485D1 (de) 2008-07-24
SI1750744T1 (sl) 2008-10-31
KR101192611B1 (ko) 2012-10-18
WO2005107791A1 (en) 2005-11-17
US20080026997A1 (en) 2008-01-31
HRP20080413T3 (en) 2008-10-31
CN1950104B (zh) 2010-11-10
KR20070007375A (ko) 2007-01-15
TW200602075A (en) 2006-01-16
DK1750744T3 (da) 2008-09-29
PL1750744T3 (pl) 2008-11-28

Similar Documents

Publication Publication Date Title
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
NL1027833A1 (nl) Verbindingen bruikbaar bij therapie.
ITRM20050265A1 (it) Protesi modulare perfezionata per osteosintesi, in particolare per l'osteosintesi dell'omero.
DK1907037T3 (da) Medikamentdispenser.
NL1028193A1 (nl) Farmaceutisch werkzame verbindingen.
DK1545662T3 (da) Lægemiddelindgivelsessystem
MA29103B1 (fr) Agents cytotoxiques comprenant de nouveaux taxanes
FR2886851B1 (fr) Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
LTC2805723I2 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
HK1103961A1 (en) Medicament for the treatment of fungal infections, particularly aspergillosis
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
DE602006002608D1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
IS8559A (is) Lyfjasamsetning gegn sveppagerlum
IS8428A (is) Innrennslislyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
FR2886852B1 (fr) Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee
ITMI20040954A1 (it) Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica
ITMI20030972A1 (it) Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
NL1023797A1 (nl) Farmaceutische doseringsvorm die zwangerschapsvriendelijke onderscheidingstekens draagt.
FR2892921B1 (fr) Injecteur d'implant ophtalmique.
ES1058102Y (es) Lentilla terapeutica.
NL1025908A1 (nl) Farmaceutische combinatie.
ITMI20032067A1 (it) Formulazione spray per il trattamento delle infezioni virali.
ITRM20030442A0 (it) Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.